As a major serine/threonine kinase, LKB1 phosphorylates and activates the AMP-activated protein kinase (AMPK), which functions to control NSCLC tumorigenesis and therapeutic response7–10. The gene discussed is STK11; the disease is non-small cell lung carcinoma.